Feasibility of oral HIV self-testing in female sex workers in Gaborone, Botswana.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
23
02
2021
accepted:
20
10
2021
entrez:
8
11
2021
pubmed:
9
11
2021
medline:
30
12
2021
Statut:
epublish
Résumé
Oral HIV self-testing (HIVST) may be useful for increasing testing in persons at elevated risk of acquiring HIV. We conducted a pilot study to evaluate the feasibility (defined by uptake) of HIVST among FSW in Gaborone, Botswana. FSW age 18 years and above were recruited through a non-governmental organization serving FSW. FSW with unknown or negative HIV status at screening performed HIVST in the study clinic following brief training. FSW testing HIV-negative were each given two test kits to take home: one kit to perform unassisted HIVST and another to share with others. Feasibility (use) of HIVST (and sharing of test kits with others) was assessed in these women at a study visit four months later. Two hundred FSW were screened. Their average age was 34 years (range 18-59), and 115 (58%) were HIV-positive. Eighty-five (42%) tested HIV-negative at entry and were eligible to take part in the HIVST pilot study. All 85 (100%) agreed to take home HIVST kits. Sixty-nine (81%) of these 85 participants had a follow-up visit, 56 (81%) of whom reported performing HIVST at a mean of three and half months after the initial visit. All 56 participants who performed HIVST reported negative HIVST results. Fifty (73%) of the 69 participants who took HIVST kits home shared them with others. Of the 50 women sharing HIVST kits, 25 (50%) shared with their non-client partners, 15 with a family member, 8 with friends, and 3 with a client. One participant did not test herself but shared both her test kits. Most participants 53/56 (95%) found oral HIVST very easy to use whilst 3/56 (5%) felt it was fairly easy. Oral HIVST is feasible among FSW in Gaborone, Botswana. The majority of FSW used the HIVST kits themselves and also shared extra HIVST kits with other individuals.
Sections du résumé
BACKGROUND
Oral HIV self-testing (HIVST) may be useful for increasing testing in persons at elevated risk of acquiring HIV.
METHODS
We conducted a pilot study to evaluate the feasibility (defined by uptake) of HIVST among FSW in Gaborone, Botswana. FSW age 18 years and above were recruited through a non-governmental organization serving FSW. FSW with unknown or negative HIV status at screening performed HIVST in the study clinic following brief training. FSW testing HIV-negative were each given two test kits to take home: one kit to perform unassisted HIVST and another to share with others. Feasibility (use) of HIVST (and sharing of test kits with others) was assessed in these women at a study visit four months later.
RESULTS
Two hundred FSW were screened. Their average age was 34 years (range 18-59), and 115 (58%) were HIV-positive. Eighty-five (42%) tested HIV-negative at entry and were eligible to take part in the HIVST pilot study. All 85 (100%) agreed to take home HIVST kits. Sixty-nine (81%) of these 85 participants had a follow-up visit, 56 (81%) of whom reported performing HIVST at a mean of three and half months after the initial visit. All 56 participants who performed HIVST reported negative HIVST results. Fifty (73%) of the 69 participants who took HIVST kits home shared them with others. Of the 50 women sharing HIVST kits, 25 (50%) shared with their non-client partners, 15 with a family member, 8 with friends, and 3 with a client. One participant did not test herself but shared both her test kits. Most participants 53/56 (95%) found oral HIVST very easy to use whilst 3/56 (5%) felt it was fairly easy.
CONCLUSION
Oral HIVST is feasible among FSW in Gaborone, Botswana. The majority of FSW used the HIVST kits themselves and also shared extra HIVST kits with other individuals.
Identifiants
pubmed: 34748576
doi: 10.1371/journal.pone.0259508
pii: PONE-D-21-06151
pmc: PMC8575243
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0259508Subventions
Organisme : NIAID NIH HHS
ID : K24 AI131928
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH058107
Pays : United States
Organisme : FIC NIH HHS
ID : R21 TW011069
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI060354
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Sex Transm Dis. 2016;2016:7673014
pubmed: 27493826
J Int AIDS Soc. 2019 Oct;22(10):e25403
pubmed: 31686432
South Afr J HIV Med. 2018 Jan 19;19(1):701
pubmed: 29568645
Afr J AIDS Res. 2016 Jul;15(2):89-98
pubmed: 27399039
AIDS Behav. 2018 Feb;22(2):497-512
pubmed: 28155039
J Int AIDS Soc. 2019 Jul;22 Suppl 4:e25319
pubmed: 31328415
PLoS One. 2017 Mar 27;12(3):e0174629
pubmed: 28346527
AIDS Behav. 2015 Nov;19(11):1949-65
pubmed: 26054390
Lancet HIV. 2018 Aug;5(8):e406-e407
pubmed: 30030133
BMC Public Health. 2017 Jun 10;17(1):565
pubmed: 28601086
AIDS Behav. 2017 Feb;21(2):501-504
pubmed: 27439457
PLoS One. 2013 Oct 15;8(10):e77080
pubmed: 24143203
J Int Assoc Provid AIDS Care. 2020 Jan-Dec;19:2325958220935691
pubmed: 32597712
Curr Opin HIV AIDS. 2016 Jan;11(1):80-6
pubmed: 26575147
PLoS One. 2014 Dec 22;9(12):e115465
pubmed: 25531771
AIDS Behav. 2016 Apr;20(4):870-9
pubmed: 26438487
BMC Med. 2020 Nov 30;18(1):373
pubmed: 33250049
PLoS One. 2020 Aug 7;15(8):e0236141
pubmed: 32764751
AIDS Behav. 2018 Feb;22(2):560-568
pubmed: 28699017
BMC Public Health. 2019 Jan 29;19(1):123
pubmed: 30696422
Curr Opin Infect Dis. 2018 Feb;31(1):14-24
pubmed: 29232277
Reprod Health. 2017 Oct 5;14(1):124
pubmed: 28982365
AIDS. 2018 Mar 13;32(5):645-652
pubmed: 29494424
Sci Rep. 2019 Sep 2;9(1):12621
pubmed: 31477764
Curr Opin HIV AIDS. 2014 Mar;9(2):174-82
pubmed: 24464089
BMC Public Health. 2019 Jan 3;19(1):7
pubmed: 30606161
BMJ Open. 2018 Nov 8;8(11):e022652
pubmed: 30413504
PLoS Med. 2011 Oct;8(10):e1001102
pubmed: 21990966
J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21101
pubmed: 27760680
Open AIDS J. 2016 Apr 08;10:34-48
pubmed: 27347270
J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):271-279
pubmed: 32168168
J Int AIDS Soc. 2017 Feb 8;20(1):21234
pubmed: 28362073
Glob Health Action. 2018;11(1):1503784
pubmed: 30092155
Lancet. 2015 Jan 3;385(9962):55-71
pubmed: 25059947
Afr J AIDS Res. 2020 Sep;19(3):186-197
pubmed: 32938320
Bull World Health Organ. 2019 Nov 1;97(11):764-776
pubmed: 31673192
PLoS One. 2020 Jul 27;15(7):e0236052
pubmed: 32716966
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Health Policy Plan. 2016 Dec;31(10):1342-1354
pubmed: 27375126
AIDS Patient Care STDS. 2017 Jul;31(7):290-296
pubmed: 28581820
PLoS Med. 2017 Nov 28;14(11):e1002458
pubmed: 29182634
PLoS One. 2014 Mar 03;9(3):e89180
pubmed: 24595029
AIDS Behav. 2015 May;19(5):899-908
pubmed: 25074736
AIDS Behav. 2019 Jan;23(1):116-125
pubmed: 30109456
PLoS Med. 2017 Nov 21;14(11):e1002442
pubmed: 29161260
BMC Public Health. 2013 Aug 08;13:735
pubmed: 23924387